Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SMA
SMA
Should Biogen's Spinraza for SMA be delayed amid COVID-19? No, say these parents
Fierce Pharma
Fri, 03/27/20 - 12:02 am
Biogen
SMA
Spinraza
COVID-19
Novartis publishes long-term data from SMA gene therapy
Pharmaforum
Tue, 03/24/20 - 10:31 am
Novartis
Zolgensma
gene therapy
SMA
Novartis faces criticism over Zolgensma ‘health lottery’
PM Live
Thu, 02/6/20 - 11:51 pm
Novartis
SMA
gene therapy
Zolgensma
lottery
Roche posts data on SMA rival to drugs from Biogen, Novartis
Fierce Biotech
Thu, 02/6/20 - 10:53 am
Roche
SMA
FDA
risdiplam
Novartis gene therapy for fatal childhood disease delivers strong sales during fourth quarter
Stat
Wed, 01/29/20 - 10:37 am
Novartis
Zolgensma
SMA
Fresh trial data fortify position of Roche's oral therapy in spinal muscular atrophy battleground
Endpoints
Thu, 01/23/20 - 11:57 am
Roche
SMA
FDA
risdiplam
Novartis' David Lennon on next steps for AveXis, selling Zolgensma's price to the public
BioPharma Dive
Wed, 01/15/20 - 11:36 pm
Novartis
SMA
AveXis
Zolgensma
drug pricing
Roche aims to 'underwhelm' with risdiplam price as it enters SMA rivalry with Biogen, Novartis — report
Endpoints
Tue, 01/14/20 - 10:20 am
SMA
Roche
risdiplam
Biogen
Novartis
drug pricing
Zolgensma for free? Yes, but advocates worry about Novartis' lottery-style giveaway
Fierce Pharma
Thu, 12/19/19 - 12:57 pm
Novartis
Zolgensma
SMA
gene therapy
drug pricing
patients
Drug Launch of the Year: Zolgensma
Biopharma Dive
Mon, 12/9/19 - 09:50 am
drug launches
Novartis
Zolgensma
SMA
Novartis pulls rival to Roche’s risdiplam in SMA, says market limited
Pharmaforum
Fri, 12/6/19 - 09:51 am
Novartis
Roche
SMA
risdiplam
branaplam
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Roche
PTC Therapeutics
SMA
risdiplam
Biogen
Spinraza
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Mon, 11/11/19 - 10:49 am
Roche
SMA
risdiplam
Biogen
Novartis
clinical trials
Novartis says delayed telling FDA of Zolgensma concern due to "mistake"
Yahoo/Reuters
Sat, 11/2/19 - 07:51 pm
Novartis
FDA
Zolgensma
SMA
Novartis Admits to ‘Mistake’ After Partial Clinical Hold Placed on Zolgensma Trial
RAPS.org
Thu, 10/31/19 - 11:54 pm
Novartis
Zolgensma
clinical trials
SMA
FDA
Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns
Stat
Wed, 10/30/19 - 10:32 am
Novartis
Zolgensma
FDA
gene therapy
clinical trials
SMA
Zolgensma hits the ground running, says Novartis
Pharmaforum
Tue, 10/22/19 - 10:33 am
Novartis
Zolgensma
AveXis
SMA
payers
Novartis' latest Zolgensma data bode well for use in older patients
Fierce Pharma
Mon, 10/7/19 - 12:13 pm
Novartis
Zolgensma
SMA
FDA
spinal muscular atrophy
Novartis in political row after denying Belgian toddler compassionate access to gene therapy
Pharmaforum
Tue, 09/24/19 - 10:01 am
Novartis
Zolgensma
SMA
compassionate use guidelines
Novartis, shadowed by data scandal, renews case for Zolgensma
Biopharma Dive
Thu, 09/19/19 - 09:56 am
Novartis
Zolgensma
SMA
spinal muscular atrophy
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »